$338 Million is the total value of Nan Fung Group Holdings Ltd's 55 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 1450.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | EXSCIENTIA PLCads | $15,219,000 | – | 770,200 | +100.0% | 4.50% | – | |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $8,816,000 | +26.4% | 210,563 | +31.4% | 2.61% | +16.8% |
| SGEN | New | SEAGEN INC | $7,010,000 | – | 45,340 | +100.0% | 2.07% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $3,514,000 | – | 171,760 | +100.0% | 1.04% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $3,036,000 | – | 11,205 | +100.0% | 0.90% | – |
| INCY | New | INCYTE CORP | $2,533,000 | – | 34,510 | +100.0% | 0.75% | – |
| NVTA | Buy | INVITAE CORP | $2,411,000 | -41.4% | 157,862 | +9.1% | 0.71% | -45.9% |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $1,695,000 | – | 12,600 | +100.0% | 0.50% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $1,505,000 | – | 48,500 | +100.0% | 0.44% | – |
| KOD | New | KODIAK SCIENCES INC | $1,139,000 | – | 13,440 | +100.0% | 0.34% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $818,000 | – | 35,035 | +100.0% | 0.24% | – |
| BLUE | New | BLUEBIRD BIO INC | $783,000 | – | 78,350 | +100.0% | 0.23% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $659,000 | – | 7,460 | +100.0% | 0.20% | – |
| New | DICE THERAPEUTICS INC | $499,000 | – | 19,700 | +100.0% | 0.15% | – | |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $435,000 | – | 9,340 | +100.0% | 0.13% | – |
| New | SURROZEN INC | $419,000 | – | 65,070 | +100.0% | 0.12% | – | |
| ARGX | New | ARGENX SEsponsored adr | $396,000 | – | 1,130 | +100.0% | 0.12% | – |
| KYMR | New | KYMERA THERAPEUTICS INC | $315,000 | – | 4,960 | +100.0% | 0.09% | – |
| New | TANGO THERAPEUTICS INC | $279,000 | – | 25,500 | +100.0% | 0.08% | – | |
| MRTX | New | MIRATI THERAPEUTICS INC | $266,000 | – | 1,810 | +100.0% | 0.08% | – |
| PRLD | New | PRELUDE THERAPEUTICS INC | $253,000 | – | 20,350 | +100.0% | 0.08% | – |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $250,000 | – | 22,200 | +100.0% | 0.07% | – |
| New | TSCAN THERAPEUTICS INC | $219,000 | – | 48,600 | +100.0% | 0.06% | – | |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $215,000 | – | 15,545 | +100.0% | 0.06% | – |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $207,000 | – | 19,150 | +100.0% | 0.06% | – |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $193,000 | – | 11,445 | +100.0% | 0.06% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $188,000 | – | 13,180 | +100.0% | 0.06% | – |
| LIFE | New | ATYR PHARMA INC | $176,000 | – | 23,500 | +100.0% | 0.05% | – |
| KURA | New | KURA ONCOLOGY INC | $163,000 | – | 11,650 | +100.0% | 0.05% | – |
| VINC | New | VINCERX PHARMA INC | $113,000 | – | 11,050 | +100.0% | 0.03% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $94,000 | – | 27,925 | +100.0% | 0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.